Therapeutic regimens and monitoring techniques for human menopausal gonadotropin administration
March, C.M.
Journal of Reproductive Medicine 21(3 Suppl): 198-204
1978
ISSN/ISBN: 0024-7758 PMID: 722708 Document Number: 128435
Document emailed within 1 workday
Related Documents
Check, J.H.; Adelson, H.G. 1984: Improvement of cervical factor by high-dose estrogen and human menopausal gonadotropin therapy with ultrasound monitoring Obstetrics and Gynecology 63(2): 179-181Rossmanith, W.G.; Sterzik, K.; Wolf, A.S. 1987: Initial experiences with subcutaneous pulsatile human menopausal gonadotropin administration: successful induction of ovulation in patients with polycystic ovarian disease International Journal of Fertility 32(6): 460-466
Molo, M.W.; Rawlins, R.G.; Binor, Z.; Kelly, M.; Radwanska, E. 1995: Luteal phase estradiol and pregnancy outcome in gonadotropin releasing hormone agonist/human menopausal gonadotropin-treated gamete intrafallopian transfer cycles Journal of Reproductive Medicine 40(6): 418-422
Yang, T.S.; Wang, B.C.; Chang, S.P.; Ng, H.T. 1995: Comparison of human menopausal gonadotropin and follicle-stimulating hormone with gonadotropin-releasing hormone agonist desensitization for controlled ovarian hyperstimulation in in vitro fertilization Zhonghua Yi Xue Za Zhi 55(6): 452-456
Fulghesu, A.M.; Lanzone, A.; Guida, C.; Nicoletti, M.C.; Rossi, P.; Le Donne, M.; Caruso, A.; Mancuso, S. 1992: Ovulation induction with human menopausal gonadotropin versus follicle-stimulating hormone after pituitary suppression by gonadotropin releasing hormone agonist in polycystic ovary disease. a cross-over study Journal of Reproductive Medicine 37(10): 834-840
Dubourdieu, S.; Charbonnel, B.; Massai, M.R.; Marraoui, J.; Spitz, I.; Bouchard, P. 1991: Suppression of corpus luteum function by the gonadotropin-releasing hormone antagonist Nal-Glu: effect of the dose and timing of human chorionic gonadotropin administration Fertility and Sterility 56(3): 440-445
Margalioth, E.J.; Navot, D.; Rabinowitz, R.; Laufer, N.; Lewin, A.; Schenker, J.G. 1986: The combined use of human menopausal gonadotropin and Parlodel (bromocriptine) for in vitro fertilization International Journal of Fertility 31(4): 278; 282-283
Reuter, K.L.; Cohen, S.; Furey, L.; Baker, S. 1996: Sonographic appearance of the endometrium and ovaries during cycles stimulated with human menopausal gonadotropin Journal of Reproductive Medicine 41(7): 509-514
Kim, C.-H.; Ahn, J.-W.; You, R.-M.; Kim, S.-H.; Chae, H.-D.; Kang, B.-M. 2014: Combined administration of gonadotropin-releasing hormone agonist with human chorionic gonadotropin for final oocyte maturation in GnRH antagonist cycles for in vitro fertilization Journal of Reproductive Medicine 59(1-2): 63-68
Zbella, E.A.; Vermesh, M.; Deppe, G.; Friberg, J. 1984: Coexistent complete hydatidiform mole and fetus after therapy with human menopausal gonadotropin. A case report Journal of Reproductive Medicine 29(10): 760-762
Toth, T.L.; Awwad, J.T.; Veeck, L.L.; Jones, H.W.; Muasher, S.J. 1996: Suppression and flare regimens of gonadotropin-releasing hormone agonist. Use in women with different basal gonadotropin values in an in vitro fertilization program Journal of Reproductive Medicine 41(5): 321-326
Scarpellini, F.; Lufino, R.; Benvenuto, P.; Scarpellini, L.; Sbracia, M. 1991: Efficacy of biochemical vs biological monitoring during the "timing" of the chorionic gonadotropin administration in FSH and HMG stimulated cycles Acta Europaea Fertilitatis 22(6): 329-332
Paszko, Z.; Padzik, H. 1970: An attempt to eliminate a high luteinizing hormone content from pituitary gonadotropin preparation of human menopausal urine origin and a further study of chorionic concentration Endokrynologia Polska 21(2): 211-218
Bringer, J.; Boulet, F.; Clouet, S.; Hedon, B.; Mares, P.; Neveu, S.; Mirouze, J.; Jaffiol, C. 1990: Pulsatile administration of gonadotropin releasing hormone in the female. Diagnostic and therapeutic indications Presse Medicale 19(27): 1276-1281
Gochman, N. 2000: Proficiency testing of therapeutic drug monitoring techniques Clinical Chemistry 46(1): 132
Santori, L.; Rastelli, M.; Arena, B.; Morleo, M.A. 1997: Cyclosporine: update on pharmacology, analytical techniques and therapeutic monitoring Bollettino Chimico Farmaceutico 136(9): 577-588
Cole, L.A.; Kohorn, E.I.; Kim, G.S. 1994: Detecting and monitoring trophoblastic disease. New perspectives on measuring human chorionic gonadotropin levels Journal of Reproductive Medicine 39(3): 193-200
Ogasa, A.; Yokoki, Y. 1971: Effects of simultaneous administration of human chorionic gonadotropin and cyproterone acetate on spermatogenesis of rat National Institute of Animal Health Quarterly 11(3): 159-167
Pedroviejo Sáez, V. 2010: On the article "Severe ovarian hyperstimulation syndrome after exogenous administration of human chorionic gonadotropin Revista Espanola de Anestesiologia y Reanimacion 57(6): 392-393
Cacciari, E.; Cicognani, A.; Tassoni, P.; Flamigni, P.; Bolelli, F.; Pirazzoli, P.; Salardi, S. 1974: Plasma testosterone and estradiol concentration in prepubertal boys with cryptorchidism before and after dexamethasone and after human chorionic gonadotropin administration Helvetica Paediatrica Acta 29(1): 27-34